Linda Pullan

Linda Pullan is the founder of Pullan Consulting, helping biotech companies with partnering, including outreach, evaluation, valuation, negotiation, and strategy.  Linda and her team have completed over 150 deals, from company acquisitions to Phase III to preclinical candidates to technologies, with deals and clients in the US, Europe, and Asia.  

After a Ph.D. in Biochemistry, Linda has 30+ years experience, first in drug discovery at Monsanto/Searle/Pfizer and ICI/Zeneca/AstraZeneca. Business development began with in-licensing technology and early drug candidates at Zeneca, and continued as head of oncology hematology licensing for Amgen. Beginning Pullan Consulting in 2006, she and her team serve as BD consultants to biotechnology and pharma companies. She has served as an expert witness, grant reviewer, CEO, and on boards for several small companies, including NLC Health Ventures. Linda has spoken at many meetings, published papers and chapters, and taught many courses in BD.